Efficacy of different combinations of antihypertensive drugs in patients with nocturnal hypertension
Journal Title: Chinese Journal of Clinical Research - Year 2024, Vol 37, Issue 1
Abstract
<b>Objective</b> To observe the efficacy of different combinations of antihypertensive drugs in patients with nocturnal hypertension (NH), and provide reference for clinical work. <b>Methods</b> A cross-sectional study was used to collect clinical data of NH patients diagnosed through ambulatory blood pressure monitoring during physical examinations at the First Affiliated Hospital of Hunan University of Medicine from January 2021 to December 2022. According to the different motheds of medication treatment for patients, NH patients were divided into single-drug group, dual-drug group and multi-drug group.Angiotensin converting enzyme inhibitor (ACEI)/ angiotensin Ⅱ receptor antagonist (ARB) or calcium antagonist was used in single-drug group, ACEI/ARB combined with calcium antagonist were used in double-drug group, and any three or four combinations of ACEI/ARB, calcium antagonists, β-blockers and diuretics were used in multi-drug group.The clinical data of the three groups of patients were analyzed and compared. <b>Results</b> There were 829 patients with NH, including 294 cases (35.46%) in single-drug group, 400 cases (48.25%) in dual-drug group and 135 cases (16.29%) in multiple-drug group. After 6 months of drug treatment, the nocturnal systolic blood pressure (NSBP) and nocturnal diastolic blood pressure (NDBP) of patients in single-drug group, dual-drug group and multi-drug group showed significant differences compared to before treatment (P＜0.05)，among them, the NSBP and NDBP of patients in dual-drug group were significantly lower than those in single-drug group and multi-drug group, but there was no significant difference between the latter two groups (P＞0.05). The decreases in NSBP and NDBP in dual-drug group (21.75%, 20.06%) were greater than those in single-drug group (17.60%, 15.26%) and multi-drug group (18.23%, 16.51%, P＜0.05), respectively. <b>Conclusion</b> All three motheds of medication treatment can effectively control nocturnal blood pressure, but ACEI/ARB combined with calcium antagonist are more effective in lowering nocturnal blood pressure.
Authors and Affiliations
LING Sha, TAN Bifeng， FU Wenzhe， CHENG Yuhua, ZHANG Xuan, LEI Jianming, ZENG Wangwei, PENG Zhiping, DING Shasha
Keywords
Related Articles
- EP ID EP735806
- DOI 10.13429/j.cnki.cjcr.2024.01.014
- Views 5
- Downloads 0
Efficacy of different combinations of antihypertensive drugs in patients with nocturnal hypertension
<b>Objective</b> To observe the efficacy of different combinations of antihypertensive drugs in patients with nocturnal hypertension (NH), and provide reference for clinical work. <b>Methods</b> A cross-sectional stu...
Study on the medication rule of Chinese medicine compound oral administration for the treatment of alopecia areata based on the national patent database
<b>Objective</b> To explore the medication rules of patented Chinese medicine compounds for oral administration in treating alopecia areata (AA), and provide reference for the treatment of AA with Chinese medicine and t...
Research progress of lung cancer complicated with pulmonary embolism
Pulmonary embolism and deep venous thrombosis are collectively referred to as venous thromboembolism, while pulmonary embolism is generally caused by deep venous thrombosis, which has the characteristics of sudden and mo...
Research progress in sensitivity to inhalation anesthetics
Inhalation anesthetics have both sedative, analgesic and muscle relaxing effects,and are widely used in clinical practice. Hypersensitivity to inhalation anesthetics predicts poor postoperative outcomes. Current studies...
Research progress of DEAD-box polypeptide 5 in breast cancer
Breast cancer, as a malignant tumor threatening the survival of women in China, its incidence rate is increasing year by year and showing a younger trend, control of cancer cell proliferation, invasion, metastasis is the...